GIP Moves from Supporting Role to Key Variable: BrightGene Bio-Medical’s Phase III Results Signal Differentiation in Weight Loss Arena
SUZHOU, China, May 12, 2026 /PRNewswire/ -- As competition in the weight loss drug market progressively intensifies, the latest Phase III clinical data disclosed by BrightGene Bio-Medical (688166.SH) for BGM0504 has reignited market attention. Mean weight reduction of 19.3%, waist circumference decrease of 16.5 cm, systolic blood pressure reduction of 22.9 mmHg in the hypertensive population, alongside uric acid reduction...
Hengrui Pharma and Bristol Myers Squibb Announce Strategic Agreements to Advance Innovative Medicines Across Oncology, Hematology, and Immunology
Landmark collaboration leverages complementary capabilities to drive speed in early innovation and help advance medicines for patients worldwide Agreements include 13 programs with the potential to address significant unmet patient needs and support long‑term growth SHANGHAI and PRINCETON, N.J., May 12, 2026 /PRNewswire/ -- Hengrui Pharma ("Hengrui") (600276.SH; 01276.HK) and Bristol Myers Squibb ("BMS") today announced the companies have...
ScienceSoft Receives Frost & Sullivan’s 2025 North America Enabling Technology Leadership Recognition for Advancing Patient Engagement and Telehealth Innovation
ScienceSoft is recognized for enabling real-time patient engagement through AI-driven conversational technologies that streamline telehealth operations and enhance care delivery. SAN ANTONIO, May 12, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that ScienceSoft has received the 2025 North America Enabling Technology Leadership Recognition in the patient engagement and telehealth industry for its outstanding achievements in innovation,...
NYSE Content Update: Eli Lilly to Celebrate 150 Years of Scientific Innovation
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, May 11, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Behind...
Ranok Therapeutics Announces the Publication of Positive Phase 1a Clinical Results for KRAS G12D Inhibitor RNK08954 in Cancer Discovery
BOSTON and HANGZHOU, China, May 11, 2026 /PRNewswire/ -- Ranok Therapeutics, a clinical-stage biotechnology company developing innovative therapies, today announced the publication of preliminary clinical results from its Phase 1a study of RNK08954 in the peer-reviewed journal Cancer Discovery. RNK08954 is a proprietary, highly selective, oral small-molecule inhibitor targeting KRAS G12D mutation in patients with advanced solid tumors. The study evaluated the...
HoneyNaps Selected for Korea’s 2026 Global ICT Unicorn Program
First SleepTech company selected for Korea's ICT Unicorn Program FDA-cleared AI sleep diagnostic solution strengthens global expansion strategy Simultaneous selection for ICT Unicorn Program and K-VIP boosts U.S. market expansion BOSTON, May 11, 2026 /PRNewswire/ -- HoneyNaps, an AI-powered sleep healthcare company, announced that it has been selected for the "2026 Global ICT Unicorn Program (ICT GROWTH)"...
Leads Biolabs R&D Symposium: Platform Synergy and Multi-Mechanism Integration Reshape the Immuno-Oncology Landscape
NANJING, China, May 11, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs"; Stock Code: 9887.HK) successfully held its R&D Symposium in Shanghai. Under the theme "Leads Innovation, Future Forward", the event comprehensively presented the Company's strategic elevation from "multi-platform synergy" to "multi-mechanism integration". Leads Biolabs highlighted its innovation ecosystem propelled by four proprietary technology platforms—IO 2.0,...
Putting humanity back into the focus of ‘technonatalism’ in assisted reproduction
BEIJING, May 11, 2026 /PRNewswire/ -- Since the world's first IVF baby was born almost 50 years ago, assisted reproductive technologies have advanced spectacularly to help millions of infertile couples to achieve their dreams of parenthood. Yet, despite the power of so-called technonatalism human reproduction is in a negative slide due to a...
Planning a Group Visit to Medtec Shanghai: A Corporate Buyer’s Guide
SHANGHAI, May 11, 2026 /PRNewswire/ -- Sourcing complex medical device components is rarely a solo job. Building a secure supply chain requires direct input from product engineering, quality control, and executive procurement teams. Sending your entire group to the Medtec China exhibition ensures that all departments align perfectly on crucial manufacturing decisions. As the premier event for medical device...
Avalere Health expands to Japan with a full-service Advisory, Medical, and Marketing offering, led by industry veteran Junji Yokokawa
Avalere Health Japan is designed with the full healthcare experience in mind, launching with an elite integrated team that brings together market access, medical, and marketing specialists, along with strategic consulting expertise. TOKYO, May 11, 2026 /PRNewswire/ -- Avalere Health, a global strategic partner for the healthcare industry, today announces the launch...
